Your browser doesn't support javascript.
loading
Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer types.
Musoro, Jammbe Z; Coens, Corneel; Sprangers, Mirjam A G; Brandberg, Yvonne; Groenvold, Mogens; Flechtner, Hans-Henning; Cocks, Kim; Velikova, Galina; Dirven, Linda; Greimel, Elfriede; Singer, Susanne; Pogoda, Katarzyna; Gamper, Eva M; Sodergren, Samantha C; Eggermont, Alexander; Koller, Michael; Reijneveld, Jaap C; Taphoorn, Martin J B; King, Madeleine T; Bottomley, Andrew.
Afiliação
  • Musoro JZ; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium. Electronic address: jammbe.musoro@eortc.org.
  • Coens C; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
  • Sprangers MAG; Amsterdam UMC Location University of Amsterdam, Medical Psychology, Amsterdam, The Netherlands; Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, The Netherlands.
  • Brandberg Y; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Groenvold M; Department of Public Health, University of Copenhagen, and Bispebjerg Hospital, Copenhagen, Denmark.
  • Flechtner HH; Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany.
  • Cocks K; Adelphi Values, Bollington, Cheshire, UK.
  • Velikova G; Leeds Institute of Medical Research at St James's, University of Leeds, St James's University Hospital, Leeds, UK; Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, St James's University Hospital, Leeds, UK.
  • Dirven L; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands; Department of Neurology, Haaglanden Medical Center, The Hague, The Netherlands.
  • Greimel E; Medical University Graz, Graz, Austria.
  • Singer S; Institute of Medical Biostatistics, Epidemiology and Informatics, Division of Epidemiology and Health Services Research, University Medical Centre Mainz, Germany; University Cancer Centre Mainz, Germany.
  • Pogoda K; Departmenf of Breast Cancer and Reconstructive Surgery, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Gamper EM; Innsbruck Institute of Patient-centered Outcome Research (IIPCOR), Innsbruck, Austria.
  • Sodergren SC; School of Health Sciences, University of Southampton, Southampton, UK.
  • Eggermont A; Princess Máxima Center, Utrecht and University Medical Center Utrecht, The Netherlands; Comprehensive Cancer Center Munich, Technical University Munich & Ludwig Maximiliaan University, Munich, Germany.
  • Koller M; Center for Clinical Studies, University Hospital Regensburg, Regensburg, Germany.
  • Reijneveld JC; Amsterdam University Medical Centers, location VU University Medical Center, Department of Neurology Brain Tumor Center, Amsterdam, The Netherlands.
  • Taphoorn MJB; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands; Department of Neurology, Haaglanden Medical Center, The Hague, The Netherlands.
  • King MT; University of Sydney, Faculty of Science, School of Psychology, Sydney, NSW, Australia.
  • Bottomley A; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
Eur J Cancer ; 188: 171-182, 2023 07.
Article em En | MEDLINE | ID: mdl-37257278

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Cabeça e Pescoço / Melanoma / Mesotelioma Tipo de estudo: Guideline / Prognostic_studies / Qualitative_research Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Cabeça e Pescoço / Melanoma / Mesotelioma Tipo de estudo: Guideline / Prognostic_studies / Qualitative_research Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article